Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.

MLA

Lu, Fei, et al. “Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.” Technology in Cancer Research & Treatment, May 2021, pp. 1–10. EBSCOhost, https://doi.org/10.1177/15330338211016369.

APA

Lu, F., Hou, Y., Chen, Z., Jiang, J., He, X., Xia, Y., Cao, K., Chang, L., & Li, W. (2021). Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials. Technology in Cancer Research & Treatment, 1–10. https://doi.org/10.1177/15330338211016369

Chicago

Lu, Fei, Yu Hou, Zhengting Chen, Jie Jiang, Xi He, Yaoxiong Xia, Ke Cao, Li Chang, and Wenhui Li. 2021. “Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.” Technology in Cancer Research & Treatment, May, 1–10. doi:10.1177/15330338211016369.